APA (7th ed.) Citation

Mosawi, Z. S. A., Abduljawad, H. O., Busehail, M. Y., & Moosawi, B. M. A. Adenosine deaminase 2 deficiency with a novel variant of CECR1 gene mutation: Responding to tumor necrosis factor antagonist therapy. SAGE Publishing.

Chicago Style (17th ed.) Citation

Mosawi, Zakiya Saleh Al, Hiba Omar Abduljawad, Maryam Yusuf Busehail, and Barrak Mahmood Al Moosawi. Adenosine Deaminase 2 Deficiency with a Novel Variant of CECR1 Gene Mutation: Responding to Tumor Necrosis Factor Antagonist Therapy. SAGE Publishing.

MLA (9th ed.) Citation

Mosawi, Zakiya Saleh Al, et al. Adenosine Deaminase 2 Deficiency with a Novel Variant of CECR1 Gene Mutation: Responding to Tumor Necrosis Factor Antagonist Therapy. SAGE Publishing.